Administration of Lactobacillus gasseri SBT2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice

British Journal of Nutrition

Volumn 114, Issue 8, 2015, Pages 1180-1187

  Ukibe, Ken ^a   Miyoshi, Masaya ^a   Kadooka, Yukio ^a  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

Inflammation; Macrophages; Obesity; Probiotics

Indexed keywords

ADIPOCYTOKINE; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR2; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR; CCL2 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL; MONOCYTE CHEMOTACTIC PROTEIN 1; NOS2 PROTEIN, MOUSE;

ABDOMINAL FAT; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CCL2 GENE; CCR2 GENE; CD68 GENE; CELL INFILTRATION; CELL INVASION; CELL POPULATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOWN REGULATION; FAT WEIGHT; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; HOMOEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE; IL6 GENE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LACTOBACILLUS GASSERI; LEP GENE; MACROPHAGE; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; NOS2 GENE; OBESITY; REAL TIME POLYMERASE CHAIN REACTION; THERAPY EFFECT; TNF GENE; WEIGHT; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; GENETICS; GLUCOSE BLOOD LEVEL; INFLAMMATION; LACTOBACILLUS; LIPID DIET; METABOLISM; MOUSE MUTANT; WEIGHT GAIN;

ABDOMINAL FAT; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHEMOKINE CCL2; DIET, HIGH-FAT; DOWN-REGULATION; ENERGY INTAKE; INFLAMMATION; INSULIN; INTERLEUKIN-6; LACTOBACILLUS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NITRIC OXIDE SYNTHASE TYPE II; OBESITY; RECEPTORS, CCR2; WEIGHT GAIN;

EID: 84944174862     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515002627     Document Type: Article

References (42)

1. Hammes WP & Tichaczek PS (1994) The potential of lactic acid bacteria for the production of safe and wholesome food. Z Lebensm Unters Forsch 198, 193-201.
2. Hill C, Guarner F, Reid G, et al. (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11, 506-514.
3. Tsai YT, Cheng PC & Pan TM (2012) The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol 96, 853-862.
4. Jan RL, Yeh KC, Hsieh MH, et al. (2012) Lactobacillus gasseri suppresses Th17 pro-inflammatory response and attenuates allergen-induced airway inflammation in a mouse model of allergic asthma. Br J Nutr 108, 130-139.
5. Lee HY, Park JH, Seok SH, et al. (2006) Human originated bacteria, Lactobacillus rhamnosus LP60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta 1761, 736-744.
6. Zhao X, Higashikawa F, Noda M, et al. (2012) The obesity and fatty liver are reduced by plant-derived Pediococcus pentosaceus LP28 in high fat-diet induced obese mice. PLOS ONE 7, e30696.
7. Park JE, Oh SH & Cha YS (2013) Lactobacillus plantarum LG42 isolated from gajami sik-hae decreases body and fat pad weights in diet-induced obese mice. J Appl Microbiol 116, 145-156.
8. Park DY, Ahn YT, Park SH, et al. (2013) Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLOS ONE 8, e59470.
9. Tsai YT, Cheng PC & Pan TM (2014) Anti-obesity effects of gut microbiota are associated with lactic acid bacteria. Appl Microbiol Biotechnol 98, 1-10.
10. Fujiwara Y, Seto A & Hashiba H (2001) Establishment of orally-Administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism. J Appl Microbiol 90, 343-352.
11. Nakayama Y, Moriya T, Sakai F, et al. (2014) Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice. Sci Rep 4, 4638.
12. Sato M, Uzu K, Yoshida T, et al. (2008) Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 99, 1013-1017.
13. Hamad EM, Sato M, Uzu K, et al. (2009) Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. Br J Nutr 101, 716-724.
14. Kadooka Y, Ogawa A, Ikuyama K, et al. (2011) The probiotic Lactobacillus gasseri SBT2055 inhibits enlargement of visceral adipocytes and up-regulation of serum soluble adhesion molecule (sICAM-1) in rats. Int Dairy J 21, 623-627.
15. Kadooka Y, Sato M, Imaizumi K, et al. (2010) Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 64, 636-643.
16. Kadooka Y, Sato M, Ogawa A, et al. (2013) Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr 110, 1696-1703.
17. Miyoshi M, Ogawa A, Higurashi S, et al. (2014) Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr 53, 599-606.
18. Chawla A, Nguyen KD & Goh YP (2011) Macrophagemediated inflammation in metabolic disease. Nat Rev Immunol 11, 738-749.
19. Fujisaka S, Usui I, Bukhari A, et al. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58, 2574-2582.
20. Xu H, Barnes GT, Yang Q, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821-1830.
21. Lumeng CN & Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121, 2111-2117.
22. Kamei N, Tobe K, Suzuki R, et al. (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281, 26602-26614.
23. Kanda H, Tateya S, Tamori Y, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116, 1494-1505.
24. Weisberg SP, Hunter D, Huber R, et al. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116, 115-124.
25. Nishimura S, Manabe I, Nagasaki M, et al. (2009) CD8 + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15, 914-920.
26. Cho KW, Morris DL & Lumeng CN (2014) Flow cytometry analyses of adipose tissue macrophages. Methods Enzymol 537, 297-314.
27. Vandesompele J, De Preter K, Pattyn F, et al. (2002) Accurate normalization of real-Time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH 0034.
28. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
29. McNelis JC & Olefsky JM (2014) Macrophage, immunity, and metabolic disease. Immunity 41, 36-48.
30. Solinas G & Karin M (2010) JNK1 and IKKβ: molecular links between obesity and metbabolic dysfunction. FASEB J 24, 2596-2611.
31. Gregor MF & Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415-445.
32. Kang YS, Lee MH, Song HK, et al. (2010) CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice. Kidney Int 78, 883-894.
33. Di Prospero NA, Artis E, Andrade-Gordon P, et al. (2014) CCR2 antagonism in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. Diabetes Obes Metab 16, 1055-1064.
34. Ying W, Kanameni S, Chang CA, et al. (2014) Interferon tau alleviates obesity-induced adipose tissue inflammation and insulin resistance by regulating macrophage polarization. PLOS ONE 9, e98835.
35. Carbone F, La Rocca C & Matarese G (2012) Immunological functions of leptin and adiponectin. Biochimie 94, 2082-2088.
36. Dib LH, Ortega MT, Fleming SD, et al. (2014) Bone marrow leptin signalling mediates obesity-Associated adipose tissue inflammation in male mice. Endocrinology 155, 40-46.
37. Wang J, Tang H, Zhang C, et al. (2015) Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 9, 1-15.
38. Musso G, Gambino R & Cassader M (2011) Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 62, 361-380.
39. Belkaid Y & Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157, 121-141.
40. Sakai F, Hosoya T, Ono-Oumachi A, et al. (2014) Lactobacillus gasseri SBT2055 induces TGF-β expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine. PLOS ONE 9, e105370.
41. Kawamoto S, Tran TH, Maruya M, et al. (2012) The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science 336, 485-489.
42. Thomas AP, Dunn TN, Oort PJ, et al. (2011) Inflammatory phenotyping identifies CD11d as a gene markedly induced in white adipose tissue in obese rodents and women. J Nutr 141, 1172-1180.